Celebrities are typically at the forefront of diet trends, and recently some have turned to diabetes drugs to shed unwanted pounds. This trend has not gone unnoticed by the public. Because obesity is a chronic condition that has become a major health issue in the United States, with more than 42% of American adults considered obese and another 31% overweight, the demand for diabetes drugs to treat weight loss is at an all time high.

Employers, who are faced with high costs in treating obesity-related chronic conditions such as hypertension and heart disease, are taking notice of these drugs as well. Studies from 2022 show that overweight employees miss more days of work and have almost twice as many workers’ compensation claims than those who are of average weight.

All of this has created a dilemma for employers. How do they control costs and still provide the best possible health care coverage that gives members access to these medications?

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.